Literature DB >> 3838099

Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries.

A L Betz.   

Abstract

Microvessel segments were isolated from rat brain and used for studies of hypoxanthine transport and metabolism. Compared to an homogenate of cerebral cortex, the isolated microvessels were 3.7-fold enriched in xanthine oxidase. Incubation of the isolated microvessels with labeled hypoxanthine resulted in its rapid uptake followed by the slower accumulation of hypoxanthine metabolites including xanthine and uric acid. The intracellular accumulation of these metabolites was inhibited by the xanthine oxidase inhibitor allopurinol. Hypoxanthine transport into isolated capillaries was inhibited by adenine but not by representative pyrimidines or nucleosides. Similar results were obtained when blood to brain transport of hypoxanthine in vivo was measured using the intracarotid bolus injection technique. Thus, hypoxanthine is transported into brain capillaries by a transport system shared with adenine. Once inside the cell, hypoxanthine can be metabolized to xanthine and uric acid by xanthine oxidase. Since this reaction leads to the release of oxygen radicals, it is suggested that brain capillaries may be susceptible to free radical mediated damage. This would be most likely to occur in conditions where the brain hypoxanthine concentration is increased as following ischemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838099     DOI: 10.1111/j.1471-4159.1985.tb05451.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

Review 1.  Reoxygenation injury of human brain capillary endothelial cells.

Authors:  T Nagashima; S Wu; M Yamaguchi; N Tamaki
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

2.  Administration of bovine superoxide dismutase prevents sequelae of spinal cord ischemia in the rabbit.

Authors:  P Cuevas; F Carceller-Benito; D Reimers
Journal:  Anat Embryol (Berl)       Date:  1989

3.  Studies on lipid peroxidation in the rat brain.

Authors:  M Cini; R G Fariello; A Bianchetti; A Moretti
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

4.  Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia.

Authors:  T Kondo; A G Reaume; T T Huang; E Carlson; K Murakami; S F Chen; E K Hoffman; R W Scott; C J Epstein; P H Chan
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

Review 5.  Clinical pharmacokinetics of allopurinol.

Authors:  G A Murrell; W G Rapeport
Journal:  Clin Pharmacokinet       Date:  1986 Sep-Oct       Impact factor: 6.447

6.  Randomised controlled trial of allopurinol prophylaxis in very preterm infants.

Authors:  G A Russell; R W Cooke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

7.  Allopurinol and oxypurinol in human breast milk.

Authors:  I Kamilli; U Gresser
Journal:  Clin Investig       Date:  1993-02

8.  Hypoxanthine transport through the blood-brain barrier.

Authors:  R Spector
Journal:  Neurochem Res       Date:  1987-09       Impact factor: 3.996

9.  Xanthine dehydrogenase/xanthine oxidase and oxidative stress.

Authors:  H Y Chung; B S Baek; S H Song; M S Kim; J I Huh; K H Shim; K W Kim; K H Lee
Journal:  Age (Omaha)       Date:  1997-07

10.  Xanthine oxidase-derived hydrogen peroxide contributes to ischemia reperfusion-induced edema in gerbil brains.

Authors:  A Patt; A H Harken; L K Burton; T C Rodell; D Piermattei; W J Schorr; N B Parker; E M Berger; I R Horesh; L S Terada
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.